The Corporate Board at Pliant Therapeutics provides strategic oversight and governance, ensuring alignment with the company's mission to advance drug development for fibrotic diseases. They make high-level decisions on corporate policies, financial planning, and regulatory compliance, while guiding long-term growth and sustainability.